Bicalutamide API

Name	Bicalutamide
Chinese name	比卡鲁胺
Cas Number	90357-06-5
Source	India
Qualifications	/-/-/-/-

Bicalutamide is a non-steroidal anti-androgen compound developed by the British company Astra Zeneca and first marketed in the UK in 1995. Bicalutamide can feedback inhibit the secretion of gonads in the anterior pituitary gland, and can reduce the production of male hormones but has almost no male hormone activity. It is the most widely used anti-androgen drug in the world. The combination of bicalutamide and luteinizing hormone releasing hormone (LHRH) can be used in the treatment of advanced prostate cancer. Compared with the first-generation anti-androgen drug flutamide, it can reduce various toxic and side effects by 70%, and its therapeutic effect Higher than flutamide. In 2016, the global prostate cancer treatment original drug market was nearly 10 billion U.S. dollars, and bicalutamide is among the TOP10 products. In 2019, the global sales of bicalutamide was RMB 1.378 billion. The GBIResearch report shows that the anti-prostate cancer drug market will grow at a compound annual growth rate (CAGR) of 8.7% by 2021, reaching a market size of $13.6 billion.

Hot Tags: bicalutamide api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Lapatinib Ditosylate API, Pabxilib API, Tavaborol API, Dapoxetine API, Escitalopram Oxalate API, Troxagliptin Succinate API

• Previous: Benzoyl Peroxide API
• Next: Terbutaline Sulfate API